Telecoms Today
SEE OTHER BRANDS

Catch up with telecommunications news from the world

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 2, 2025

ProMOS Adopts Silvaco Victory TCAD Solution for the Development of Next-Gen Silicon Photonics Devices

ProMOS Adopts Silvaco Victory TCAD Solution for the Development of Next-Gen Silicon Photonics Devices

SANTA CLARA, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and …

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

Biogen’s Investigational Tau-Targeting Therapy BIIB080 Receives FDA Fast Track Designation for the Treatment of Alzheimer’s Disease

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to BIIB080, an investigational antisense oligonucleotide (ASO) therapy …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

American Tungsten Corp. Joins The Critical Mineral Institute

American Tungsten Corp. Joins The Critical Mineral Institute

Vancouver, BC, April 02, 2025 (GLOBE NEWSWIRE) -- American Tungsten Corp. (CSE:TUNG) (OTCQB:DEMRF) (FSE:RK9) (“American Tungsten” or the “Company”) is pleased to announce that it has become a member of the Critical Minerals Institute (the “CMI”). The CMI …

Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board

Grove AI Welcomes Former Novartis, UCB, and Google Executives to Company Advisory Board

SAN FRANCISCO, April 02, 2025 (GLOBE NEWSWIRE) -- Grove AI, pioneer in life science automation using agentic AI, today announced the formation of its inaugural Advisory Board. Comprised of prominent leaders from pharmaceutical and technology sectors, the …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

US …

Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health

Moringa: Learn Why These Moringa Powder Supplements Are Transforming Energy, Immunity, and Overall Health

LAS VEGAS, April 02, 2025 (GLOBE NEWSWIRE) -- Moringa Oleifera, often called the “Miracle Tree,” is rapidly gaining recognition in the U.S. as a superfood for its remarkable health benefits. From boosting daily energy levels to fortifying immune support, …

Defiance Launches $GLDY, Gold Enhanced Options Income ETF

Defiance Launches $GLDY, Gold Enhanced Options Income ETF

MIAMI, April 02, 2025 (GLOBE NEWSWIRE) -- Defiance ETFs is proud to announce the launch of GLDY, the Defiance Gold Enhanced Options Income ETF. GLDY offers investors a new opportunity to seek current income while gaining indirect exposure to the price …

Cartesian Therapeutics Announces New Employment Inducement Grants

Cartesian Therapeutics Announces New Employment Inducement Grants

FREDERICK, Md., April 02, 2025 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering cell therapies for the treatment of autoimmune diseases, today announced the granting of …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer

Building on Past Success, Incident IQ Names Ryan Zeek as Chief Financial Officer

ATLANTA, April 02, 2025 (GLOBE NEWSWIRE) -- Incident IQ, the leading workflow management platform built specifically to streamline K-12 school districts, has announced the appointment of Ryan Zeek as Chief Financial Officer. Ryan steps into the role after …

SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student

SchoolAI Secures $25 Million to Help Teachers and Schools Reach Every Student

LEHI, Utah, April 02, 2025 (GLOBE NEWSWIRE) -- SchoolAI, a leading AI platform for teaching and learning, today announced it has closed $25 million in Series A funding to tackle education’s fundamental challenge: helping teachers provide personalized …

The NHL and Rogers Announce Monumental 12-Year National Media Rights Deal

The NHL and Rogers Announce Monumental 12-Year National Media Rights Deal

Renews highly coveted and valuable hockey rights long term Will deliver more national games and fewer blackouts to hockey fans Rogers is proud to remain the home of NHL hockey TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Rogers Communications and the …

Prospect’s Real Estate Private Credit Platform Provides $10.9 Million to Class A Stabilized Cash Flowing Multifamily Property in Brooklyn

Prospect’s Real Estate Private Credit Platform Provides $10.9 Million to Class A Stabilized Cash Flowing Multifamily Property in Brooklyn

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Management L.P. (“Prospect”), through its real estate private credit platform, has closed on an investment to recapitalize The Frederick, a 193-unit, Class A stabilized cash flowing multifamily …

La LNH et Rogers annoncent un accord monumental de 12 ans pour les droits de diffusion nationaux

La LNH et Rogers annoncent un accord monumental de 12 ans pour les droits de diffusion nationaux

Ces droits très convoités et d’une grande valeur sont renouvelés à long terme L’accord promet aux fans de hockey plus de matchs nationaux et moins de rencontres frappées par des interdictions de diffusion Rogers est fière de demeurer la destination …

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment

Antag Therapeutics initiates Phase 1a trial of AT-7687, a first-in-class GIPR antagonist designed to address key gaps in obesity treatment First subjects dosed in double-blind, placebo-controlled trial assessing AT-7687’s safety, tolerability, …

Le secteur de la construction au Manitoba devrait connaître une croissance saine de l’activité résidentielle et non résidentielle d’ici 2034

Le secteur de la construction au Manitoba devrait connaître une croissance saine de l’activité résidentielle et non résidentielle d’ici 2034

OTTAWA, Ontario, 02 avr. 2025 (GLOBE NEWSWIRE) -- L’activité de construction a enregistré une légère hausse au Manitoba en 2024, la croissance du secteur non résidentiel de la province ayant contrebalancé un léger ralentissement du secteur résidentiel. Au …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service